November is Eye Donation Month, a time to raise awareness about the life-changing impact of cornea donation. It's also a time ...

Kygevvi is indicated for patients with thymidine kinase 2 deficiency whose symptoms arise by 12 years of age. The disease ...

Delhi's eyes are under siege from pollution and relentless screen time, leading to a surge in dry eye disease. Smog irritates, while reduced blinking ...

Delhi's air pollution, known for respiratory issues, is now scientifically proven to harm vision. Fine particles and toxic ...

Epioxa by Glaukos Corp received US Food and Drug Administration (FDA) approval on 20 October as the first and only ...

Q3 2025 Earnings Call Transcript October 30, 2025 Operator: Ladies and gentlemen, thank you for standing by. My name is Colby ...

The Eye Care Network sat down with Rajesh K. Rajpal, MD, ophthalmologist and founder of See Clearly Vision Group in McLean, Virginia, to discuss what this novel therapeutic means for managing ...

The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare corneal disease a treatment option that does not require incisions.

Glaukos Corp. today announced it received FDA approval for Epioxa, an eye therapy made to stop the progression of keratoconus.

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. There are way more bats than you might think. Second only to rodents ...

Michael J. Fox is hoping his death isn't "dramatic" after battling Parkinson's disease for the past 35 years. Fox opened up about his future with the "mysterious" disease, which he was first diagnosed ...

The FDA has adjusted the label of Johnson & Johnson and Legend Biotech’s Carvykti, warning patients and doctors that use of the multiple myeloma treatment could increase the risk of an intestinal ...